Settlement Reached in Genetic Testing Fraud Case
Whistleblower Law Collaborative LLC is proud to announce a significant legal victory involving a $6 million settlement related to a genetic testing fraud case. This settlement directly addresses claims made by whistleblowers against Genexe, LLC operating under the name Genexe Health, Immerge, Inc., and two key individuals, Jason Green and Jason Gross.
Understanding the Settlement Terms
As part of the government settlement, Genexe, Immerge, Green, and Gross have agreed to collectively pay $6 million to resolve allegations raised in several qui tam lawsuits related to fraudulent practices in genetic testing. This settlement will award whistleblowers and clients of WLC a total of $1.3 million, acknowledging their courageous contributions in bringing these allegations to light.
Allegations of Fraudulence in Genetic Testing
The False Claims Act allegations stem from activities between 2018 and 2019 when certain individuals and companies were found to have submitted false claims for genetic tests that were not medically necessary. Genetic tests are designed to detect genetic mutations that may influence a person’s health risks or treatment responses. However, claims were made for tests that had been acquired through questionable means, including kickbacks to a network comprising independent contractors, labs, and medical professionals.
Accountability of Company Executives
A key aspect of this settlement is the accountability demonstrated by executive officers Jason Green and Jason Gross, who were pivotal in the operations of Genexe and Immerge. As CEO and COO, respectively, they played significant roles in managing the companies and will jointly share the financial responsibilities of the settlement alongside their businesses.
Government Stance on Genetic Testing Fraud
In a statement regarding the settlement, federal officials articulated the critical need to combat genetic testing fraud and its detrimental impact on both the healthcare system and taxpayers. They stressed the necessity of ensuring that medical testing is genuinely beneficial for patients rather than being driven by profit motives.
"Fraud in genetic testing exploits patient anxieties and squanders taxpayer resources by promoting unnecessary testing processes," explained a representative from the U.S. Attorney's office. The enforcement of strict measures against such fraudulent activities underlines the government’s commitment to protecting healthcare integrity.
Recognition for the Clients’ Contributions
WLC has expressed its gratitude towards its clients who took brave steps by coming forward and shedding light on the fraudulent actions that impacted vulnerable communities. Attorney Bruce C. Judge emphasized how critical whistleblowers are in exposing widespread fraud, ensuring that those responsible are held accountable.
"Our clients played a vital role in informing authorities about this deceitful scheme that victimized many, especially older adults. This settlement marks the tireless efforts of dedicated legal practitioners and investigators tirelessly working toward justice," Judge noted.
A History of Advocacy Against Genetic Testing Fraud
This settlement marks a significant continuation in WLC's mission, as it represents the third substantial breakthrough in cases regarding genetic testing fraud initiated by their clients. Since raising awareness of these scams in 2018, WLC has been actively engaged in monitoring and addressing such malpractice.
Contacting Whistleblower Law Collaborative
WLC, which dedicates its practice to supporting whistleblowers, encourages individuals to seek help with any concerns about fraud. For further information, individuals can reach out to the WLC team directly at 617.366.2800 or contact their partners for dedicated support.
Frequently Asked Questions
What was the outcome of the genetic testing fraud case?
The outcome was a $6 million settlement involving Genexe, Immerge, and their executives.
How much will whistleblowers receive from the settlement?
Whistleblowers will collectively receive $1.3 million as part of the settlement.
What is the significance of this settlement?
This settlement emphasizes accountability and the government's dedication to fighting fraud in healthcare.
Who were the main individuals involved in the case?
The main individuals involved were Jason Green and Jason Gross, executives of the involved companies.
How does this impact future genetic testing practices?
The settlement aims to deter fraudulent practices and promote the integrity of genetic testing in healthcare.
